Here are the 10-Q quarterly reports from MRC Global Inc. (MRC) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow MRC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MRC filings page.
MRC Global Inc. (MRC) filed its Q3 2025 10-Q, reporting softer results and progress toward its merger with DNOW. Sales were $678 million, down from $771 million, and the quarter showed an operating loss of $3 million and a net loss of $9 million. For the first nine months, sales were $2,188 million versus $2,347 million a year ago, with net income from continuing operations of $12 million.
The planned all-stock merger with DNOW advances: each MRC share will convert into 0.9489 DNOW shares at closing, subject to customary closing conditions. Stockholders of both companies approved the deal on September 9, 2025; the HSR waiting period expired October 6, 2025, and required regulatory approvals were received on November 3, 2025.
Cash was $59 million with operating cash flows of $(67) million year-to-date. Debt totaled $476 million, including the Senior Secured Term Loan B and $134 million drawn on the Global ABL Facility, which had $477 million of availability at September 30, 2025. Year-to-date, the company repurchased 1,216,956 shares for $15 million. MRC completed the sale of its Canada operations in March, contributing a nine-month loss from discontinued operations of $30 million.